Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2013 Feb 10;131(6):1691–1693. doi: 10.1016/j.jaci.2013.01.004

FIG 1.

FIG 1

Gain-of-function STAT1 mutations increase PD-L1 expression. A, Pedigree with patients (black) and carriers (gray) heterozygous at STAT1 nucleotide 705. B, Increased STAT1 phosphorylation in IL-21 treated T-cells from patients (filled), compared to controls (solid) and unstimulated (dashed). C, Reduced TH17-cell frequencies in E235A STAT1 patients. D, PD-L1 overexpression on CD3+CD4+CD62L+CD45RO cells from subjects with STAT1 mutations (filled) versus controls (solid).